IP Library Granted Patent US 8,235,939
Granted Patent B2
US 8,235,939 · App. 11/717,893 · Granted Aug 7, 2012

System and method for purging a reduced pressure apparatus during the administration of reduced pressure treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,235,939
App. No.
11/717,893
Granted
Aug 7, 2012
Kind
B2
Abstract

A reduced pressure delivery system for applying a reduced pressure to a tissue site is provided. The system includes a manifold having a plurality of flow channels. The manifold is configured to be placed adjacent the tissue site. A first conduit is in fluid communication with the flow channels of the manifold to deliver a reduced pressure to the flow channels. A second conduit is in fluid communication with the flow channels of the manifold and is operably connected to a valve. The valve selectively purges the second conduit with ambient air when the valve is positioned in an open position, and a controller is operably connected to the valve to place the valve in the open position for a selected amount of time at a selected interval during delivery of reduced pressure through the first conduit.

Claims (38)

1. A method of administering a reduced pressure tissue treatment to a tissue site comprising:

positioning a primary manifold having apertures in fluid communication with a secondary manifold;

positioning the secondary manifold having a plurality of flow channels adjacent the tissue site such that at least a portion of the flow channels are in fluid communication with the tissue site, wherein the secondary manifold prevents direct contact between the primary manifold and the tissue site;

applying a reduced pressure to the tissue site through the secondary manifold from a first conduit having at least one outlet in fluid communication with the flow channels; and

purging blockages in or near the first conduit by delivering a fluid through a second conduit in an area in proximity to the at least one outlet of the first conduit.

2. The method according to claim 1 , wherein the pressure of the fluid is greater than the reduced pressure.

3. The method according to claim 1 , wherein the fluid is chosen from the group of filtered air and nitrogen.

4. The method according to claim 1 , wherein the reduced pressure is applied cyclically.

5. The method according to claim 1 , wherein the fluid is delivered through the second conduit during a time period when reduced pressure is applied.

6. The method according to claim 5 , wherein the fluid flow rate is less than the rate of flow due to the reduced pressure.

7. The method according to claim 5 , wherein the fluid flow rate is less than 1/10 th of the rate of flow due to the reduced pressure.

8. The method according to claim 5 , wherein the fluid flow rate is less than 1/100 th of the rate of flow due to the reduced pressure.

9. The method according to claim 1 , wherein the tissue site includes hard tissue.

10. The method according to claim 1 , wherein the tissue site includes soft tissue.

11. The method according to claim 1 , wherein the tissue site is comprised of tissue selected from the group of adipose tissue, muscle tissue, neural tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, and ligaments.

12. The method according to claim 1 , wherein the first and second conduits are lumens within a multi-lumen tube.

13. The method according to claim 1 , wherein the first and second conduits are separate tubes.

14. The method according to claim 1 , wherein the fluid is filtered to prevent entry of contaminants prior to delivery.

15. The method according to claim 1 , wherein the secondary manifold is a cellular foam.

16. A method of administering a reduced pressure tissue treatment to a tissue site comprising:

positioning a primary manifold having apertures in fluid communication with a secondary manifold;

positioning the secondary manifold having a plurality of flow channels adjacent the tissue site such that at least a portion of the flow channels are in fluid communication with the tissue site, wherein the secondary manifold prevents direct contact between the primary manifold and the tissue site;

applying a reduced pressure to the tissue site through the secondary manifold from a first conduit having at least one outlet in fluid communication with the flow channels; and

opening a valve operably associated with a second conduit to expose the conduit to a fluid at a pressure greater than the reduced pressure, the valve being opened for a selected amount of time at a selected interval to allow the fluid to be delivered through the second conduit to assist in clearing blockages within or near the first conduit.

17. The method according to claim 16 , wherein:

the selected amount of time is about two seconds; and

the selected interval is about sixty seconds.

18. The method according to claim 16 , wherein the fluid is a gaseous fluid.

19. The method according to claim 16 , wherein the gaseous fluid is chosen from the group of filtered air, oxygen, and nitrogen.

20. The method according to claim 16 , wherein the fluid is chosen from the group of antibacterial agents, antiviral agents, cell-growth promotion agents, irrigation fluids, chemically-active fluids, and analgesics.

21. The method according to claim 16 , wherein the reduced pressure is applied cyclically.

22. The method according to claim 16 , wherein the fluid is delivered through the second conduit during a time period when reduced pressure is applied.

23. The method according to claim 16 , wherein the tissue site includes hard tissue.

24. The method according to claim 16 , wherein the tissue site includes soft tissue.

25. The method according to claim 16 , wherein the tissue is comprised of tissue selected from the group of adipose tissue, muscle tissue, neural tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, and ligaments.

26. The method according to claim 16 , wherein the first and second conduits are lumens within a multi-lumen tube.

27. The method according to claim 16 , wherein the first and second conduits are separate tubes.

28. The method according to claim 16 , wherein the secondary manifold is a cellular foam.

Assignments (13)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
RELEASE OF SECURITY INTEREST Recorded Sep 21, 2016
From: WILMINGTON TRUST
To: KCI LICENSING, INC.; LIFECELL CORPORATION; KINETIC CONCEPTS, INC.; TECHNIMOTION, LLC
Reel/Frame 040098/0200 →
SECURITY AGREEMENT Recorded Nov 8, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 027194/0447 →
SECURITY AGREEMENT Recorded Nov 7, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027185/0174 →
RELEASE OF SECURITY INTEREST Recorded May 30, 2008
From: CITIBANK, N.A.
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; KCI HOLDING COMPANY, INC.; KCI LICENSING, INC.; KCI INTERNATIONAL, INC.
Reel/Frame 021018/0130 →
SECURITY AGREEMENT Recorded Aug 2, 2007
From: KCI LICENSING, INC.; KINETIC CONCEPTS, INC.; KCI USA, INC.; KCI HOLDING COMPANY, INC.; KCI INTERNATIONAL, INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 019640/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2007
From: JOHNSON, ROYCE W.; JAEB, JONATHAN PAUL; SWAIN, LARRY D.; CORNET, DOUGLAS A.; MANWARING, MICHAEL; KAGAN, JONATHAN; HEATON, KEITH PATRICK; LOCKE, CHRISTOPHER BRIAN; ROBINSON, TIMOTHY MARK
To: KCI LICENSING, INC.
Reel/Frame 019285/0216 →